Molecular Archives

11Oct

Invivoscribe Controls Portfolio Catalogue 2024

Discover the Invivoscribe control portfolio

Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls.

BCR/ABL1, cell line dna, cGMP conditions, control, DNA, FLT3 ITD, flt3 tkd, general purpose reagents, igh-bcl2, invivoscribe, minimal residual disease, MRD, next-generation sequencing assays, NGS, plasmid dna, tissue dna

08Oct

Molecular

Think Biocartis Idylla

WHEN TIME MATTERS. THINK BIOCARTIS IDYLLA*. YOUR BIOMARKER TEST RESULTS WITHIN 3 HOURS.

The Idylla™ solution is a revolutionary, fully automated, real-time PCR based molecular testing system designed to offer results in a minimum amount of time.

AKT1, ALK, biocartis, braf, EGFR, GeneFusion, IDH1-2, idylla, KRAS, METex14, msi, NGS, nras, NTRK, NTRK1, NTRK2, NTRK3, PIK3CA, RET, ROS1

18Sep

Molecular

ZytoVision – Now IDVR Certified

Abacus dx are thrilled to announce ZytoVision* received their In Vitro Diagnostics Regulation (IVDR) certification for its selected product portfolio.

in vitro, In Vitro Diagnostics Regulation, ivdr, zytovision

25Jun

Molecular

Asuragen – QuantideX BCR-ABL

Asuragen’s Precision Oncology Solutions.

Revolutionising Precision Oncology with QuantideX^®: Where Sensitivity Meets Scalability

asuragen, chronic myeloid leukaemia, leukaemia, oncology, qPCR BCR-ABL IS Kit, qPCR BCR-ABL minor Kit, quantidex

28May

Molecular

Invivoscribe NPM1 MRD Assay

Just launched! NPM1 MRD Assay* by Invivoscribe.

AML, assay, cytogenetics, FLT3, FLT3 ITD, invivoscribe, MRD, NPM1

09May

Molecular

Biocartis Idylla™ GeneFusion Assay*

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Within 180 minutes and with less than 2 minutes hands-on time, the fully automated Idylla™ GeneFusion cartridge detects ALK, ROS1, RET, NTRK1/2/3 rearrangements and MET exon 14 skipping in a single cartridge using only 1-3* FFPE tissue sections.

ALK, biocartis, GeneFusion, idylla, NTRK, NTRK1, NTRK2, NTRK3, RET, ROS1

14Apr

Molecular

Devyser thalassemia NGS

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Reduce turnaround time and simplify laboratory workflow with a rapid full-spectrum sequencing single-assay thalassemia DNA screening solution that eliminates multiple parallel test protocols.

12Apr

Molecular

Biocartis – Clinical utility of Idylla EGFR

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Within 150 minutes and with less than 2 minutes hands-on time, the fully automated Idylla™ EGFR Mutation Test covers 51 mutations in exons 18–21 in a single cartridge

biocartis, cancer, EGFR, idylla, lung cancer, NSCLC

21Mar

Molecular